In the news

News headlines are articles that reference ResMed's company, people, or business practices.

Advanced Search
  • October 29, 2018
    Med Device Online

    ResMed SaaS leader Sarah Wright spoke about her initiative to utilize all available data to get to the truth of the customer experience, and to evolve overall offerings to best meet those needs.

  • October 15, 2018
    Health Europa

    Vice-president of medical affairs at ResMed, discusses the high burden of sleep apnoea in Europe and how best the health community can respond.

  • October 10, 2018
    MedCity News

    How ResMed and other companies use technology to provide a more holistic approach to patient's health, or even to get them past the mental barriers to improving their lifestyles.

  • September 11, 2018
    MedTech Talk

    Today, CEO Mick Farrell has ResMed beginning to take a very different path, migrating away from pure medical device sales and into selling software and other tech services to physicians.

  • August 8, 2018
    The Constant Investor (subscription)

    A 20-minute interview with ResMed President and COO Rob Douglas about the company's recent revenue growth, and how it plans to sustain it moving forward.

  • July 31, 2018
    Pharma Intelligence

    ResMed recognized for developing AirMini, "an innovative medical device or diagnostic that makes significant contributions to advancing patient treatment, and was launched between January 1, 2017 and May 31, 2018.”

  • July 30, 2018
    University of Washington

    A mobile technology conceived and researched at the University of Washington’s Paul G. Allen School of Computer Science & Engineering and UW Medicine designed to track breathing and body movements without requiring contact with the human body, has helped inspire the active sonar portion of the just-launched SleepScore mobile application, available worldwide to iOS and Android users.

  • July 12, 2018
    CNBC

    ResMed and Verily are investing an undisclosed amount in the as-yet-unnamed venture, and is focused on sleep apnea and other sleep breathing disorders. This is not the first time that Verily has partnered with a life sciences company for a joint venture: It is also working with Johnson & Johnson on an effort called Verb Surgical to develop a next-generation surgical robot.

  • June 15, 2018
    HME News

    ResMed and Xealth have launched a pilot project that allows primary care physicians at Providence St. Joseph Health to access data from CPAP devices right from their electronic medical record software.

  • Sleep Review logo
    June 3, 2018
    Sleep Review

    A new ResMed-funded retrospective study explores a potential factor of long-term adherence: mask resupply programs.

  • Mass Device logo
    May 21, 2018
    MassDevice

    ResMed today released data from two clinical analyses exploring combined home oxygen therapy and non-invasive ventilation therapy for patients with persistent hypercapnia following a life-threatening exacerbation of COPD, touting an increase in cost efficiency with the combined therapy.

  • April 27, 2018
    HME News

    ResMed reported 16% growth on a constant currency basis in the third quarter [of Fiscal Year 2018] for Europe, Asia and other markets, compared to 8% in the second quarter.

  • MD+DI logo
    April 24, 2018
    MD+DI

    One of medtech’s most connected health technology companies has just hired its first chief technology officer.

  • April 16, 2018
    Sleep Review

    Once a PAP user has a full-face mask that fits properly, Justus offers these tips for clinicians and patients on keeping the fit “just right": Magnets or a marker; regular cleaning; and scheduled resupply.

  • April 15, 2018
    San Diego Business Journal (subscription)

    In recent years, strong demand and a digital transformation spurred ResMed’s growth. The company posted $2.07 billion in 2017 revenue, up 37.1 percent from 2013, when Farrell took over as CEO. The company’s market cap went from $6 billion to nearly $14 billion in this span. Farrell said the market remains vastly underpenetrated. He’s pushing big data to break through.

  • April 3, 2018
    Medical Design & Outsourcing

    One company, ResMed (NYSE: RMD), has taken on the challenge of helping users become more compliant, the ecosystem more cost-effective and customers more loyal through a model of connected health. San Diego–based ResMed’s quest to improve patient compliance began over a decade ago, explained CEO Mick Farrell. “We started our first digital health experiments with UC San Diego in 2002 and learned a lot over a decade.”

  • February 21, 2018
    CommonWell Alliance

    Why did we at Brightree embrace FHIR for our connectivity with CommonWell and other portions of our interoperability solutions sets? We are writing today to help folks understand how we view FHIR fitting into the post-acute interoperability world and our interoperability commitment.

  • February 7, 2018
    News release

    The GEMCO-Brightree partnership simplifies the ordering process for DME/HME dealers by allowing them to place GEMCO orders directly from the Brightree Integrated ePurchasing platform. This streamlined process allows providers to reduce costs and increase revenue with no additional charge for integration.

  • January 19, 2018
    HomeCare

    “One of the greatest benefits of connected health is its ability to segment patient populations in the ways that will more efficiently help patients and their home care providers,” says Jeremy Malecha, VP of SaaS Strategy Development for ResMed. “Among sleep apnea patients, for instance, it’s crucial for HMEs to know how well their patients are adhering to PAP (positive airway pressure) therapy. When the right information is presented quickly and clearly, HMEs can more easily determine which patients need what types of support to improve health outcomes—and prioritize based on urgency and available resources.”

  • December 8, 2017
    Berg Insight

    Berg Insight estimates that the installed base of connected sleep therapy devices reached 3.4 million units at the end of 2016, which can be compared with 2.0 million units in 2015. The rapid increase is to a large extent due to ResMed’s push in the market. ResMed has established itself as the clear market leader in remote monitoring of sleep therapy patients with an estimated 2.0 million connected patients at the end of 2016.

  • December 6, 2017
    MD+DI

    ResMed has been named a 2017 “Medtech Company of the Year” finalist by MD+DI, a leading news resource in the medical device and diagnostic industry.

  • November 7, 2017
    mobiHealthNews

    Monitoring sleep disorders while traveling just became easier this week after the San Diego based company, ResMed announced that the AirMini, a miniature CPAP device, will now to be able to connect to the AirView, a remote patient monitoring platform.

  • October 2, 2017
    Seeking Alpha

    ResMed I thought was a great BUY in the $60 per share range, and a good buy at $73. It still is for investors after topping an all-time high price.

  • September 14, 2017
    San Diego Business Journal

    San Diego-based companies like ResMed and NuVasive Inc. argue the tax stifles research and development, job creation and innovation.

  • September 12, 2017
    HME News

    The use of CPAP telemonitoring with automated feedback messaging improved 90-day adherence in patients with obstructive sleep apnea, according to a ResMed-supported study published in American Journal of Respiratory and Clinical Care Medicine.

  • September 5, 2017
    Parks Associates

    Kari Hall, VP, Global Software Services at ResMed, recently spoke with Parks Associates about the future of healthcare. Kari was also a speaker at Parks Associates’ annual Connected Health Summit in San Diego, where she and speakers from 2bPrecise, Kaiser, Qualcomm, and UPMC Insurance Services spoke about the business opportunities available through precision medicine.

  • August 27, 2017
    RT Magazine

    “Because ALS is a progressive disease, many patients receive NIV via a life support device, like ResMed’s Astral ventilator, which can be utilized throughout the course of the disease," said Denise Hartsell, RRT, RPSGT, Senior Product Manager, Ventilation at ResMed.

  • August 8, 2017
    Frequent Business Traveler

    A close family member was recently diagnosed with sleep apnea and we’ve found that traveling with his home therapy equipment was an onerous imposition. With that in mind I recently went hunting for portable equipment to use instead. My conclusion? There was just one machine worth considering: the AirMini from ResMed.

  • August 7, 2017
    UC San Diego

    This year, six new trustees, including ResMed CEO Mick Farrell, and two returning trustees will join the 2017-18 Foundation Board.

  • Sleep Review
    August 4, 2017
    Sleep Review

    Proponents say oral appliances can be made faster and more accurately when intraoral scanning, computer-aided design, and computer-aided manufacturing (CAD/CAM) are utilized.

  • July 19, 2017
    S&P Dow Jones Indices

    Effective prior to the open of trading on Wednesday, July 26: S&P MidCap 400 constituents ResMed Inc. (NYSE:RMD), Packaging Corporation of America (NYSE:PKG), A.O. Smith Corp. (NYSE:AOS) and Duke Realty Corp.
    (NYSE:DRE) will replace Mallinckrodt plc (NYSE:MNK), Murphy Oil Corp (NYSE:MUR), Bed Bath & Beyond Inc. (NASD:BBBY) and Transocean Ltd (NYSE:RIG) respectively, in the S&P 500.

  • July 5, 2017
    HME News

    Brightree announced today that it has bought AllCall Connect, a Joliet, Ill.-based provider of live-calling solutions for CPAP patient resupply, its second acquisition in as many months.

  • June 28, 2017
    ABC News: Good Morning America

    ABC News' Paula Faris shares the story of how she found out her husband's snoring was caused by sleep apnea and looks at some possible snoring solutions.

  • June 13, 2017
    Sleep Review

    A large study finds that ASV yields better compliance among obstructive sleep apnea patients who develop treatment-emergent central sleep apnea than does CPAP. Researchers discuss why and what it means in clinical practice.

  • June 13, 2017
    Medical Devices

    This presentation is a must for anyone who wants to understand how dramatically the smart use of big data can impact the entire healthcare system. With ResMed’s investments in digitization, they are lowering costs for sleep apnea and COPD therapy and increasing patient adherence.

  • June 9, 2017
    Sleep Review

    Boosted by launches [like ResMed's AirMini], the market for small positive airway pressure devices has never been bigger.

  • June 7, 2017
    mHealth Intelligence

    Healthcare providers are using mobile health technology to transform clunky CPAP devices into high-tech mHealth platforms, giving doctors better insight into sleep and breathing problems.

  • June 5, 2017
    Bloomberg (starts at 27:40)

    ResMed Chief Medical Officer Carlos M. Nunez, M.D., discussed sleep apnea, why ResMed connected 3 million sleep devices to the cloud, and his thoughts on sleep trackers, with Bloomberg Baystate Business Hour host Anne Mostue.

  • May 25, 2017
    Journal of Translational Medicine

    The recognition and treatment of sleep-disordered breathing is vital for the continued health and wellbeing of individual patients with SDB.

  • May 22, 2017
    PCHAlliance

    The Personal Connected Health Alliance (PCHAlliance) today announced the addition of twelve new member companies during the first quarter of 2017, including five at the Global level -- AT&T, Eli Lilly and Company, IPSOS Healthcare, ResMed and Samsung. As a Global Member, each had the opportunity to nominate an executive to the PCHAlliance Board of Managers and all have been accepted.

  • May 21, 2017
    MedPage Today

    Patients with persistent hypercapnia following an acute exacerbation of chronic obstructive pulmonary disease (COPD) had a longer time to death or rehospitalization if non-interventional ventilation was added to their home oxygen therapy, researchers found.

  • May 16, 2017
    Sleep Review

    ResMed Inc announced that people with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant on therapy after they switch from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to the largest-ever analysis of patients with treatment-emergent CSA.

  • May 8, 2017
    Becker's Hospital Review

    Amy Cook, Director of Healthcare Informatics at ResMed, was named to Becker's list of 110 Women in Medtech to Know in 2017. Joining ResMed in 2012, she was integral in developing and rolling out the company's suite of connected health IT services and platforms.

  • Medgadget logo
    May 3, 2017
    Medgadget

    The S+ platform is the newest technology disrupting the $60B consumer sleep industry. Developed by SleepScore Labs, a joint venture between ResMed, a 25-year leader in prescription sleep medical devices, Dr. Mehmet Oz, and Pegasus Capital Advisors, the S+ is a clinical grade, non-prescription, non-contact sleep monitoring device coupled with a mobile app.

  • San Diego Union-Tribune logo
    April 25, 2017
    San Diego Union-Tribune

    Instead of packing up their larger, bedside machines from home for a trip, sleep apnea patients can travel with a much smaller device, according to the company. It’s akin to taking a tablet on the road while leaving the desktop computer at home, said ResMed Chief Executive Michael “Mick” Farrell.

  • Xconomy logo
    April 25, 2017
    Xconomy

    The debut of ResMed’s AirMini is only part of a bigger picture, according to Jim Hollingshead, ResMed’s president of the Americas. Hollingshead said the AirMini is part of a strategic shift that began four or five years ago, when ResMed began to pivot from developing medtech hardware to becoming a provider of “connected healthcare.”

  • HME Business
    April 13, 2017
    HME Business

    Individuals with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant with their therapy after switching from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to a broad survey of sleep patients patients with treatment-emergent CSA that was commissioned by sleep equipment maker ResMed.

  • FeibusTech
    April 10, 2017
    FeibusTech

    Mike Feibus tries S+, the world's first non-contact sleep tracker, discusses what it does, what it has, and more.

  • ATS logo
    April 4, 2017
    American Thoracic Society

    The American Thoracic Society today announced a new $100,000 two-year research fellowship funded by ResMed in the area of noninvasive ventilation (NIV) in chronic obstructive pulmonary disease (COPD).

Show 5102550100 per page
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages